Exenatide (EXE) (2 mg weekly), Dapagliflozin (DAPA) (10 mg daily), Exenatide + Dapagliflozin (2 mg weekly/10 mg daily), Dapagliflozin (10 mg) + Metformin (MET) (2000 mg extended release daily), or Phentermine (7.5 mg)/Topiramate were given to the patients for 24 weeks (46 mg extended release daily)
Possible dangers include pancreatitis, kidney disease, and gastrointestinal issues
This documentation strengthens your case for FSA reimbursement and ensures your therapy aligns with clinical guidelines
Some patients notice reduced cravings or less interest in food during this phase, but actual weight change is usually minimal at this stage
But in recent years, theres been legislation pending in Congress that, if passed, could help ensure that GLP-1s may be covered by both Medicaid and Medicare for weight loss